The Australasian Gastro-Intestinal Trials Group (AGITG) is the only research organisation in the Australasian region with a focus on gastro-intestinal cancers.
The AGITG Annual Scientific Meeting is widely known throughout Australasia as the premier meeting in the gastro-intestinal (GI) cancer space. The three day meeting provides gastro-intestinal cancer clinicians, researchers and allied health specialists with the opportunity to present their research and discuss current challenges and innovations, as well as to hear from international and local leaders on the latest in research and treatments. The exchange of knowledge and expertise is strongly encouraged in our friendly and collegiate meeting environment. The meeting also provides an opportunity for involvement of health professionals in the scientific activities of the AGITG.
The program structure consists of three days of dedicated program which include keynote sessions featuring international guest speakers, plenary and symposia sessions, trials presentations, poster session, new concepts symposium and workshops.
The AGITG recognises excellence in the Posters and Fast Forward Sessions and the New Concepts Symposium at each annual meeting. The winning presenters in the Posters Session and New Concepts Symposium receive a $3,500 prize and framed certificate. The winner presenter in the Fast Forward session and the runner up in the New Concepts Symposium receive $1,500 and a framed certificate. The Awards are presented at the Annual Scientific Meeting Dinner and details of the Award recipients are published on the AGITG website and in the Annual Report. The Awards provide an excellent opportunity to be recognised by peers for contributions to the Group and annual meeting.
The Executive Organising Committee is working to present a dynamic program of interest to all involved in the care of patients with gastro-intestinal cancer.
We look forward to seeing you in Brisbane!
Prof Eva Segelov
AGITG Annual Scientific Meeting Convenor
Mr Russell Conley
AGITG Chief Executive Officer
“I find the AGITG Annual Scientific Meeting to be an invaluable learning experience. Like many things, what you put in correlates with what you take away. My efforts to submit a new concept proposal were rewarded when it was selected for oral presentation at the New Concepts Symposium at the 2014 meeting. This led to invaluable feedback and ongoing support from the AGITG which has ultimately led to a completed protocol and a study opening to recruitment in March 2018. This is such an exciting outcome for my research career and I have the AGITG to thank for it. The invited faculty is always first class and this meeting provides ample opportunity to network with the faculty (from Australia and overseas) hence learn so much more than just what is delivered in lectures. I can thoroughly recommend attendance at the AGITG Annual Scientific Meeting.”Dr Matthew Burge
Royal Brisbane & Women’s Hospital
Winner of the 2014 Best New Concept Award and recipient of the 2016 Innovation Grant for the MONARCC Study: A randomised Phase II study of panitumumab monotherapy versus panitumumab and 5 Fluorouracil as first line treatment for RAS and RAF wild type metastatic colorectal cancer (mCRC).
“The AGITG Annual Scientific Meeting is like a big, happy, empowering trans-national multi-disciplinary team meeting where state of the art management and current trials are tossed around by key craft groups. For Radiation Oncologists, the RO specific session is invaluable. There is generally an invited speaker who comments on our art during a contouring workshop which is always interactive and inclusive. Several RO contouring guidelines have been published directly consequent to these workshops.”Associate Professor George Hruby
Genesis Cancer Care, Sydney
“The AGITG ASM is a multidisciplinary meeting focussed on the current and future management of GI cancer. It provides not only high quality educational material across the spectrum of GI cancer, but encourages the presentation of new clinical trial ideas. Through the New Concepts Symposium, clinical trial concepts are presented and refined for development into national or international studies. The meeting is suitable for trainees and senior clinicians as well as paramedical practitioners engaged in all aspects of GI cancer management.”Professor Andrew Barbour
Princess Alexandra Hospital, Brisbane
“I attended my first AGITG Annual Scientific Meeting as an advanced trainee newly starting a PhD. It was a great educational meeting that had instructive symposia with an interesting and approachable local and international faculty. Those features have been present at each AGITG ASM that I have subsequently attended, and I have found the ASM to be an invaluable forum for presentation of research, less formal discussion of research themes and ideas, and learning about the challenges involved in clinical trial design. The AGITG ASM environment supports collaboration and networking, and I would highly recommend the meeting to all trainees, researchers, investigators and clinicians who have an interest in gastro-intestinal cancers.”Dr Sharon Pattison
University of Otago and Southern District Health Board, Dunedin
“Key to the AGITG philosophy is a desire to improve the health and quality of life of people with gastro-intestinal cancer by conducting high quality collaborative clinical trials. In developing and conducting these trials the AGITG has successfully encompassed specialists, nurses, research coordinators, scientists, allied health professionals and consumers.
The AGITG Annual Scientific Meeting provides an excellent forum for all these disciplines to come together to share knowledge and experiences and learn from a wide variety of invited international speakers. Incorporated in the meeting are sessions specifically targeting study coordinators and allied health professionals. Speakers and topics for interactive discussion are chosen to complement the annual theme of the meeting and address issues that may arise from a study coordinator perspective.
This is a valuable meeting and excellent opportunity to learn more about clinical trials, changes in medical practice and to exchange ideas and experiences with other study coordinators.”Ms Anne Smith
Clinical Trials Manager
Christchurch Oncology Research Unit
Canterbury Regional Cancer and Haematology Service
“I find the AGITG Annual Scientific Meeting a great meeting to attend. It is a great opportunity to learn where GI cancer research and practice is heading with many opportunities to network and collaborate. I found the New Concepts process highly supportive, encouraging and a fantastic learning process – it has stimulated my research to a new level, for which I am grateful for the opportunity.”Dr Katherine Geddes
Medical Oncologist & Oncology Research Fellow
St Vincent’s Hospital, Melbourne
Winner of the 2017 Best New Concept Award
“The AGITG Annual Scientific Meeting always provides a great opportunity for networking and hearing about cutting-edge research being undertaken in Australia. The mix of clinical trial updates and scientific presentations, along with the varied session formats, makes the meeting interesting and valuable for clinicians, scientists and study co-ordinators alike. I found the 2017 meeting a very enjoyable and informative meeting and was honoured to be awarded the Award for the best presentation in the Fast-Forward session, where I had the opportunity to present on behalf of PhD candidate, Tim Miller.”Melanie McCoy
PhD | Research Fellow
St John of God Subiaco Hospital, Perth
Winner of the 2017 Best Fast-Forward presentation
“As a Clinical Trials Coordinator I was extremely grateful for the opportunity to attend the AGITG 2017 Annual Scientific Meeting in Cairns last year. Through attending the Scientific Sessions I was able to listen to a number of internationally renowned guest speakers, which included gastro-intestinal cancer clinicians, researchers and delegates, and clinical trials management personnel. I found these sessions very informative and interesting and it enhanced my awareness and knowledge regarding research in current and future clinical trials, and feedback on relevant data from closed trials.
I found attending the Study Coordinator Forum most valuable as I was able to meet and share experiences with, and gain knowledge from, other study coordinators from institutions throughout Australia and New Zealand. I was also able to meet and listen to key speakers from the AGITG, including key researchers and clinical trials management personnel, which provided me with the opportunity to both reinforce knowledge and keep me updated on the progress of current and upcoming clinical trials.
I feel the opportunity to attend the AGITG ASM has been of great value to my professional development and practice, as it has provided me the opportunity to increase my understanding of the role of the AGITG and the important contributions it makes towards gastro-intestinal cancer research. This will assist in my day to day practice as it will ensure smoother coordination of trials on which I am working and provide me with greater insight and knowledge which in turn can be provided to colleagues and patients with whom I work.”Kim Adlard
RN/Clinical Trials Coordinator
Centre for Clinical Research
Haematology and Oncology
Royal Hobart Hospital
“The AGITG Annual Scientific Meeting is a thoroughly enjoyable conference for all involved in GI cancer. The AGITG have a longstanding commitment to education and invite a high calibre of international and local speakers to deliver an informative program. As an early-career delegate, the conference provided me with a forum to present my research and meet likeminded clinicians, researchers and new collaborators.”Dr David Lau
Clinical Research Fellow
Olivia Newton John Cancer Research Centre
Recipient of the 2018 Merck-AGITG Clinical Research Fellowship
“The 2017 AGITG Annual Scientific Meeting was a true meeting of the minds in Gastrointestinal Oncology, where research ideas were fostered and refined in a collegial, friendly atmosphere. The meeting was the perfect forum to bring GI oncology specialists from across Australia and New Zealand as well as across disciplines to interact and discuss new directions for clinical trials based on the latest updates from the recently completed and ongoing clinical trials for GI malignancies. As an international attendee, I was impressed by the collaborative spirit that has been established across Australia and New Zealand to support clinical trial development and implementation. The educational component was exceptional, with both local and international experts speaking on a diverse range of topics. The case discussions were particularly stimulating and sparked thought-provoking discussion on controversial clinical scenarios in GI malignancies as well as where we need to focus future research.”Professor Karyn A. Goodman, MD, MS
University of Colorado Cancer Center
2017 Invited Faculty
“It was great pleasure and honour to be invited to Queensland to participate in the AGITG 2017 annual meeting. The atmosphere and environment encouraged discussion, collaboration and invention as such a meeting of dedicated individuals should do. Additionally the ability to get to know colleagues personally enables the research environment hugely. As such the intention of the meeting to encourage collaborative research was extremely effectively met as well as being fun. I had extremely interesting and enjoyable time: thank you Tim and Eva and friends.”Professor John Bridgewater
UCL Cancer Institute, London
2017 Invited Faculty
“As a medical oncologist from Canada, I thoroughly enjoyed the 2017 AGITG Scientific Meeting. The mix of clinical and research topics covers all oncological specialties, which allows for productive multi-disciplinary exchanges. The meeting is also the occasion to meet many experts from Australia and New Zealand plus some well-known international speakers. Add to these features a rich and entertaining social program and you have one of the best GI cancer conferences I attended during the year.”Associate Professor Thierry Alcindor
Center for Innovative Medicine, McGill University Health Centre, Montreal
2017 Visiting Representative of the Canadian Cancer Trials Group